Skip to main content
. 2025 Aug 25;22:83. doi: 10.1186/s12981-025-00783-z

Table 1.

Sociodemographic, clinical and behavioral characteristics of study participants, Accra, Ghana

Characteristic Frequency (n = 347) n (%) MetS status n (%) P-value
Present(n = 53) Absent (n = 294)
Sex
 Male 135 (38.9) 19 (14.1) 116 (39.5) 0.62
 Female 212 (61.1) 34 (64.2) 178 (60.6)

Age Median (25th–75th percentiles)

38 (29–45)

 < 25 42 (12.1) 3 (5.7) 39 (13.3) 0.02*
 25–49 253 (72.9) 36 (67.9) 217 (73.8)
 > 50 52 (14.9) 14 (26.4) 38 (12.9)
BMI (kg/m2)
 Underweight: <18.5 80 (23.1) 18 (34.6) 143 (25.5) < 0.00*
 Healthy: 18.5–24.9 166 (47.8) 6 (11.5) 74 (49.3)
 Overweight: 25–30 53 (15.3) 9 (17.3) 44 (15.2)
 Obese: >30 48 (13.8) 19 (36.5) 29 (10.0)
WHO HIV Clinical stage at enrolment
 Stage 1 176 (50.7) 29 (54.7) 147 (50.0) 0.46
 Stage 2 83 (23.9) 12 (22.6) 71 (24.2)
 Stage 3 75 (21.6) 12 (22.6) 63 (21.4)
 Stage 4 13 (3.8) 0 (0.0) 13 (4.4)
Alcohol consumption
 Never consumed 220 (63.4) 30 (56.6) 190 (64.6) 0.12
 Previous drinker 33 (9.5) 9 (16.9) 24 (8.2)
 Current drinker 94 (27.1) 14 (26.4) 80 (27.2)
Smoking
 Never smoked 306 (88.2) 49 (92.5) 257 (87.4) 0.49
 Previous smoker 27 (7.8) 2 (3.8) 25 (8.5)
 Current smoker 14 (4.0) 2 (3.8) 12 (4.1)
Exercise habits
 No exercise 55 (15.9) 7 (13.2) 48 (16.3) 0.52
 Low Intensity 143 (57.1) 19 (35.9) 124 (42.2)
 Moderate Intensity 68 (19.6) 14 (26.4) 54 (18.4)
 High Intensity 81 (23.3) 13 (24.5) 68 (23.1)
Number of MetS Sub-Components at baseline
 None 33 (9.5) 33 (11.2) < 0.00*
 One 121 (34.9) 121 (41.2)
 Two 140 (40.4) 140 (47.6)
 Three 46 (13.3) 46 (86.8) 0 (0.0)
 Four 7 (2.0) 7 (13.2) 0 (0.0)

BMI = Body Mass Index; HIV = Human Immunodeficiency Virus; MetS = Metabolic Syndrome; WHO = World Health Organization

*Statistically significant